Stephen K. Van Den Eeden
Kaiser Permanente
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen K. Van Den Eeden.
Obstetrics & Gynecology | 2001
Leslee L. Subak; L. Elaine Waetjen; Stephen K. Van Den Eeden; David H. Thom; Eric Vittinghoff; Jeanette S. Brown
OBJECTIVE To estimate the annual direct cost to society of pelvic organ prolapse operations in the United States. METHODS We multiplied the number of pelvic organ prolapse operations identified in the 1997 National Hospital Discharge Survey by national average Medicare reimbursement for physician services and hospitalizations. Although this reimbursement does not estimate the actual cost, it is a proxy for cost, which estimates what society pays for the procedures. RESULTS In 1997, direct costs of pelvic organ prolapse surgery were
Nature Genetics | 2009
Laufey Amundadottir; Peter Kraft; Rachael Z. Stolzenberg-Solomon; Charles S. Fuchs; Gloria M. Petersen; Alan A. Arslan; H. Bas Bueno-de-Mesquita; Myron D. Gross; Kathy J. Helzlsouer; Eric J. Jacobs; Andrea Z. LaCroix; Wei Zheng; Demetrius Albanes; William R. Bamlet; Christine D. Berg; Franco Berrino; Sheila Bingham; Julie E. Buring; Paige M. Bracci; Federico Canzian; Françoise Clavel-Chapelon; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J. Duell; John W. Fox; Steven Gallinger; J. Michael Gaziano; Edward Giovannucci; Michael Goggins
1012 million (95% confidence interval [CI]
Obstetrics & Gynecology | 2007
Guri Rortveit; Jeanette S. Brown; David H. Thom; Stephen K. Van Den Eeden; Jennifer M. Creasman; Leslee L. Subak
775, 1251 million), including
Obstetrics & Gynecology | 2006
Ilana B. Addis; Stephen K. Van Den Eeden; Christina Wassel-Fyr; Eric Vittinghoff; Jeanette S. Brown; David H. Thom
494 million (49%) for vaginal hysterectomy,
The Lancet | 2012
Johannes R. Kratz; Jianxing He; Stephen K. Van Den Eeden; Zhihua Zhu; Wen Gao; Patrick Pham; Michael Mulvihill; Fatemeh Ziaei; Huanrong Zhang; Bo Su; Xiuyi Zhi; Charles P. Quesenberry; Laurel A. Habel; Qiuhua Deng; Zongfei Wang; Jiangfen Zhou; Huiling Li; Mei-Chun Huang; Che-Chung Yeh; Mark R. Segal; M Roshni Ray; Kirk D. Jones; Dan J. Raz; Zhidong Xu; Thierry Jahan; David Berryman; Biao He; Michael J. Mann; David M. Jablons
279 million (28%) for cystocele and rectocele repair, and
The Journal of Urology | 2006
David H. Thom; Stephen K. Van Den Eeden; Arona Ragins; Christina Wassel-Fyr; Eric Vittinghof; Leslee L. Subak; Jeanette S. Brown
135 million (13%) for abdominal hysterectomy. Physician services accounted for 29% (
JAMA | 2015
James D. Lewis; Laurel A. Habel; Charles P. Quesenberry; Brian L. Strom; Tiffany Peng; Monique M. Hedderson; Samantha F. Ehrlich; Ronac Mamtani; Warren B. Bilker; David J. Vaughn; Lisa Nessel; Stephen K. Van Den Eeden; Assiamira Ferrara
298 million) of total costs, and hospitalization accounted for 71% (
JAMA Neurology | 2009
Annette Langer-Gould; Stella M. Huang; Rohit Gupta; Amethyst Leimpeter; Eleni Greenwood; Kathleen Albers; Stephen K. Van Den Eeden; Lorene M. Nelson
714 million). Twenty‐one percent of pelvic organ prolapse operations included urinary incontinence procedures (
Diabetes Care | 2011
Assiamira Ferrara; James D. Lewis; Charles P. Quesenberry; Tiffany Peng; Brian L. Strom; Stephen K. Van Den Eeden; Samantha F. Ehrlich; Laurel A. Habel
218 million). If all operations were reimbursed by non‐Medicare sources, the annual estimated cost would increase by 52% to
Diseases of The Colon & Rectum | 2006
Madhulika G. Varma; Jeanette S. Brown; Jennifer M. Creasman; David H. Thom; Stephen K. Van Den Eeden; Mary S. Beattie; Leslee L. Subak
1543 million. CONCLUSION The annual direct costs of operations for pelvic organ prolapse are substantial.
